• Home
  • About Us
  • Authors
  • Contact Us
  • Privacy Policy
  • Accessibility
  • Terms of Use
facebook
lastfm
linkedin
tumblr
pinterest
  • Sports
  • Entertainment
  • Automotive
  • Technology
  • Fashion and Lifestyle
  • World
  • Featured
  • Investment
BREAKING NEWS
Francesca’s Holdings Corp (NASDAQ:FRAN): Sales Up by 17%
Google Inc (NASDAQ:GOOG) to launch Glass app store next year
Rise in Ford Motor Company (NYSE:F) sales figures
Dollar General Corp. (NYSE:DG) exhibited better second quarter results
Kinder Morgan Inc (NYSE:KMI) Targets $30 Levels - Exit
Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) – Will Target $9.50 Above $7.60
General Motors Company (NYSE:GM) – Buy On Dips With Stop Loss Below $32.50
Boston Scientific Corporation (NYSE:BSX) – Uptrend Intact Till $10.50 Is Protected
CBS Corporation (NYSE:CBS): Blackout Ends Right Before NFL!
Jarden Corp (NYSE:JAH): Eyeing Scented Growth With Yankee Candle

Tag

//Johnson & Johnson (NYSE:JNJ)
0

Buy Johnson & Johnson (NYSE:JNJ) And Forget It

There are stocks and there are stocks, like Johnson & Johnson (NYSE:JNJ) (Closed: $90.40, Up: 0.46%) which one should most probably buy and keep in the lockers and forget all about it. It can be trusted to go up and only up for years to come. Rarely you can see such a stock,...
Posted On 16 Jul 2013
, By Lisa Johnson
0

“Invoking” sales via new drugs- Johnson & Johnson (NYSE:JNJ) tops analyst estimates

Northern, WI 04/17/2013 (avauncer) - The world’s largest healthcare products-maker Johnson & Johnson (NYSE:JNJ) (Closed: $83.44, Up by: 2.12%)’s first quarter earnings have topped analyst projections as its acquisition of Synthes Inc and launch of new drugs boosted...
Posted On 17 Apr 2013
, By Mark
0

Johnson & amp; Johnson (NYSE:JNJ)’ De Puy wins implant case

Northern, WI 04/17/2013 (avauncer) - Johnson & Johnson (NYSE:JNJ) (Closed: $83.44, Up by: 2.12%)’s De Puy unit had a victory of sorts in the trial of an Illinois woman’s claim that her health had been harmed metal-on-metal implant that had been designed by the company....
Posted On 17 Apr 2013
, By Lisa Johnson
0

Five companies which can find a breakthrough solution for Alzheimer disease- ABT, LLY, JNJ, NVS, PFE

Northern, WI 03/13/2013 (avauncer) - There are five companies poised to find a breakthrough treatment for Alzheimer’s disease. They include the likes of Abbott Laboratories (NYSE:ABT), Eli Lilly & Co. (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Novartis AG – ADR...
Posted On 13 Mar 2013
, By Viraj Shah
0

Jury verdict- Johnson & Johnson (NYSE:JNJ) will pay $8.3 million compensatory charges

Northern, WI 03/10/2013 (avauncer) –The metal-on metal hip implant manufactured by Johnson & Johnson (NYSE:JNJ)’ DePuy unit has been found to have severe defects and 93,000 units were recalled by the company in 2010. Of the 10,750 lawsuits that have been filed, the first one...
Posted On 10 Mar 2013
, By Karen Kinsey
0

Celgene Psoriasis Drug helps 75% of Cancer patients - CELG, AMGN PFE, ABBV & JNJ

Northern, WI 03/04/2013 (avauncer) - Celgene Corp (NASDAQ:CELG) is known for its cancer drug Revlimid. Now the company stated that its experimental Psoriasis drug is showing reduction in redness and inflammation of the skin problem, it’s still in study stage. Based on...
Posted On 04 Mar 2013
, By Sophia.Mark
Copyright 2013 Avauncer Inc. All Right Reserved. Powered by Avauncer Media.